Caraco Pharma

Interact & exchange stock tips & market info »
Related News »
finding that a district court judge was right to conclude in 2009 that Danish pharma giant Novo Nordisk A/S must correct information it provided to the Food and Drug Administration about its diabetes drug Prandin. The decision should allow Caraco ...
May 16, 2012 at 18:45 | Source: Law.com